Analysis of patterns of failure and appraisal of postoperative radiation field for grade II–III meningioma.
- Published in:
- Journal of Neuro-Oncology, 2019, v. 144, n. 2, p. 333, doi. 10.1007/s11060-019-03232-w
- By:
- Publication type:
- Article
Works matching AU Jason Joon Bock Lee
Results: 16
1
2
Increased Radiosensitivity of Solid Tumors Harboring ATM and BRCA1/2 Mutations.
- Published in:
- Cancer Research & Treatment, 2022, v. 54, n. 1, p. 54, doi. 10.4143/crt.2020.1247
- By:
- Publication type:
- Article
3
Dosimetric outcomes of preoperative treatment planning with intraoperative optimization using stranded seeds in prostate brachytherapy.
- Published in:
- PLoS ONE, 2022, v. 17, n. 3, p. 1, doi. 10.1371/journal.pone.0265143
- By:
- Publication type:
- Article
4
Medical student education through flipped learning and virtual rotations in radiation oncology during the COVID-19 pandemic: a cross sectional research.
- Published in:
- 2021
- By:
- Publication type:
- journal article
5
Evaluation of Pretreatment Albumin–Bilirubin Grade as a Better Prognostic Factor Compared to Child–Pugh Classification in Patients with Hepatocellular Carcinoma Receiving Transarterial Chemoembolization Combined with Radiotherapy.
- Published in:
- Journal of Personalized Medicine, 2023, v. 13, n. 2, p. 354, doi. 10.3390/jpm13020354
- By:
- Publication type:
- Article
6
Predictive factors of symptomatic radiation pneumonitis in primary and metastatic lung tumors treated with stereotactic ablative body radiotherapy.
- Published in:
- Radiation Oncology Journal, 2017, v. 35, n. 2, p. 163, doi. 10.3857/roj.2017.00066
- By:
- Publication type:
- Article
7
In vivo dosimetry and acute toxicity in breast cancer patients undergoing intraoperative radiotherapy as boost.
- Published in:
- Radiation Oncology Journal, 2017, v. 35, n. 2, p. 121, doi. 10.3857/roj.2017.00150
- By:
- Publication type:
- Article
8
Dual Oxidase 2 (DUOX2) as a Proteomic Biomarker for Predicting Treatment Response to Chemoradiation Therapy for Locally Advanced Rectal Cancer: Using High-Throughput Proteomic Analysis and Machine Learning Algorithm.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 21, p. 12923, doi. 10.3390/ijms232112923
- By:
- Publication type:
- Article
9
Risk factor analysis of dental implants in patients with irradiated head and neck cancer.
- Published in:
- Head & Neck, 2022, v. 44, n. 8, p. 1816, doi. 10.1002/hed.27080
- By:
- Publication type:
- Article
10
Combining deep-inspiration breath hold and intensity-modulated radiotherapy for gastric mucosa-associated lymphoid tissue lymphoma: Dosimetric evaluation using comprehensive plan quality indices.
- Published in:
- 2019
- By:
- Publication type:
- journal article
11
Adjuvant Radiotherapy Versus Surveillance for Grade 2 Intracranial Meningiomas: A Multi-Institutional Propensity Score-Matched Study.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.877244
- By:
- Publication type:
- Article
12
Klinische Sicherheit und Wirksamkeit der Salvage-Rebestrahlung bei bösartigen Tumoren im oberen Abdominalbereich.
- Published in:
- 2019
- By:
- Publication type:
- journal article
13
Prostate-Specific Antigen Bounce after 125 I Brachytherapy Using Stranded Seeds with Intraoperative Optimization for Prostate Cancer.
- Published in:
- Cancers, 2022, v. 14, n. 19, p. 4907, doi. 10.3390/cancers14194907
- By:
- Publication type:
- Article
14
Clinical Implications of Geometric and Dosimetric Uncertainties of Inter- and Intra-Fractional Movement during Volumetric Modulated Arc Therapy for Breast Cancer Patients.
- Published in:
- Cancers, 2021, v. 13, n. 7, p. 1651, doi. 10.3390/cancers13071651
- By:
- Publication type:
- Article
15
Dual‐Functional Hafnium Oxide Nanoplatform Combining High‐Z Radiosensitization With Bcl‐2 Gene Silencing for Enhanced Cancer Radiotherapy (Adv. Healthcare Mater. 15/2025).
- Published in:
- Advanced Healthcare Materials, 2025, v. 14, n. 15, p. 1, doi. 10.1002/adhm.202570089
- By:
- Publication type:
- Article
16
Dual‐Functional Hafnium Oxide Nanoplatform Combining High‐Z Radiosensitization With Bcl‐2 Gene Silencing for Enhanced Cancer Radiotherapy.
- Published in:
- Advanced Healthcare Materials, 2025, v. 14, n. 15, p. 1, doi. 10.1002/adhm.202404819
- By:
- Publication type:
- Article